Rachel joined the Oxford Vaccine Group (OVG) in May 2017 as a Project Manager. Prior to this, she worked in several laboratories as a technician before moving to the Nuffield Department of Obstetrics and Gynaecology where she coordinated the INTERBIO-21st project, a international multi-site study investigating the effects of nutrition and infection on the growth and development of infants in healthy and complicated pregnancies.
As Project Manager within OVG, Rachel’s role is to manage the clinical trials being conducted to ensure timely and efficient completion.
Heterogeneous alleles comprising G6PD deficiency trait in West Africa exert contrasting effects on two major clinical presentations of severe malaria.
Shah SS. et al, (2016), Malar J, 15
Genetic determinants of anti-malarial acquired immunity in a large multi-centre study.
Shelton JMG. et al, (2015), Malar J, 14